AAV vectors
US6521225B1 · kind B1 · utility
27Cited by
4References
6Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Sep 2, 1997 |
| Grant date | Feb 18, 2003 |
| Priority date | — |
| Expiry date | Sep 2, 2017 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2750/14143
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to a recombinant adenovirus vector comprising two inverted terminal repeats (ITRs) each of which comprises a D-sequence having (i) from 5 to 15 native nucleotides and (ii) one or more deletions or substitutions therein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.